Interdisciplinary Analysis of HIV-Specific CD8+ T Cell Responses against Variant Epitopes Reveals Restricted TCR Promiscuity
暂无分享,去创建一个
O. Lund | M. Nielsen | I. Hoof | A. Karlsson | M. Buggert | R. Gustafsson | C. Perez
[1] D. Ge,et al. HLA-C cell surface expression and control of HIV / AIDS correlate with a variant upstream of HLA-C , 2009 .
[2] R. Koup,et al. Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response. , 2009, Blood.
[3] Todd M. Allen,et al. HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphocyte Recognition , 2009, Journal of Virology.
[4] Xiping Wei,et al. Kinetics of Expansion of Epitope-Specific T Cell Responses during Primary HIV-1 Infection1 , 2009, The Journal of Immunology.
[5] Philippe Froguel,et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). , 2009, The Journal of infectious diseases.
[6] H. Schuitemaker,et al. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection , 2009, AIDS.
[7] Morten Nielsen,et al. Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods , 2009, Bioinform..
[8] Bin Li,et al. HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition , 2008, Journal of Virology.
[9] Philip J. R. Goulder,et al. Impact of MHC class I diversity on immune control of immunodeficiency virus replication , 2008, Nature Reviews Immunology.
[10] Morten Nielsen,et al. Broadly Immunogenic HLA Class I Supertype-Restricted Elite CTL Epitopes Recognized in a Diverse Population Infected with Different HIV-1 Subtypes1 , 2008, The Journal of Immunology.
[11] Morten Nielsen,et al. Amino Acid Similarity Accounts for T Cell Cross-Reactivity and for “Holes” in the T Cell Repertoire , 2008, PloS one.
[12] O. Lund,et al. NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.
[13] O. Lund,et al. NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence , 2007, PloS one.
[14] Jacques Fellay,et al. A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 , 2007, Science.
[15] D. Nixon,et al. Antiretroviral Drug Therapy Alters the Profile of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses and Shifts the Immunodominant Cytotoxic T-Lymphocyte Response from Gag to Pol , 2007, Journal of Virology.
[16] S. Oka,et al. Altering Effects of Antigenic Variations in HIV-1 on Antiviral Effectiveness of HIV-Specific CTLs1 , 2007, The Journal of Immunology.
[17] D. Nixon,et al. Sequential Broadening of CTL Responses in Early HIV-1 Infection Is Associated with Viral Escape , 2007, PloS one.
[18] E. Rosenberg,et al. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily. , 2006, International immunology.
[19] D. Cornforth,et al. HIV-1 Epitope-Specific CD8+ T Cell Responses Strongly Associated with Delayed Disease Progression Cross-Recognize Epitope Variants Efficiently1 , 2006, The Journal of Immunology.
[20] Tao Dong,et al. Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope , 2006, Nature Immunology.
[21] J. Goedert,et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis , 2005, Nature Medicine.
[22] Galit Alter,et al. High degree of inter-clade cross-reactivity of HIV-1-specific T cell responses at the single peptide level , 2005, AIDS.
[23] Todd M. Allen,et al. The Majority of Currently Circulating Human Immunodeficiency Virus Type 1 Clade B Viruses Fail To Prime Cytotoxic T-Lymphocyte Responses against an Otherwise Immunodominant HLA-A2-Restricted Epitope: Implications for Vaccine Design , 2005, Journal of Virology.
[24] Daniel C. Douek,et al. T Cell Cross-Reactivity and Conformational Changes during TCR Engagement , 2004, The Journal of experimental medicine.
[25] A. Sette,et al. Recognition of Variant HIV-1 Epitopes from Diverse Viral Subtypes by Vaccine-Induced CTL1 , 2004, The Journal of Immunology.
[26] Derek Middleton,et al. New allele frequency database: www.allelefrequencies.net , 2003 .
[27] Feng Gao,et al. Diversity Considerations in HIV-1 Vaccine Selection , 2002, Science.
[28] R. Brunham,et al. HLA-A and HLA-B in Kenya, Africa: allele frequencies and identification of HLA-B*1567 and HLA-B*4426. , 2002, Tissue antigens.
[29] Ian A Wilson,et al. The specificity of TCR/pMHC interaction. , 2002, Current opinion in immunology.
[30] F. Buseyne,et al. The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes. , 2001, International immunology.
[31] Bette T. Korber,et al. Immune control of HIV: the obstacles of HLA and viral diversity , 2001, Nature Immunology.
[32] E. Rosenberg,et al. Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV Infection , 2001, The Journal of experimental medicine.
[33] H. Etlinger,et al. the Journal of Immunology , 2006 .
[34] J. Yewdell,et al. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.
[35] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[36] R. Germain,et al. Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture. , 1997, Human immunology.
[37] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[38] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[39] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[40] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[41] S. Henikoff,et al. Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[42] William S. Lane,et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.
[43] A. Rudensky,et al. Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.
[44] Hidde L. Ploegh,et al. Peptide selection by MHC class I molecules , 1991, Nature.